These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serotonin selectivity for obsessive compulsive and panic disorders. Montgomery SA, Bullock T, Fineberg N. J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935 [No Abstract] [Full Text] [Related]
3. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Blier P, de Montigny C. Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494 [Abstract] [Full Text] [Related]
10. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Lee JH, Dunner DL. Depress Anxiety; 2008 Jul 17; 25(2):91-7. PubMed ID: 17311265 [Abstract] [Full Text] [Related]
11. Guidelines on psychotropic drugs for the EC. Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder. Eur Neuropsychopharmacol; 1995 Jun 17; 5(2):151-5. PubMed ID: 7549458 [No Abstract] [Full Text] [Related]
12. [Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders]. Rosenberg R. Ugeskr Laeger; 2001 Apr 02; 163(14):1985-91. PubMed ID: 11307357 [Abstract] [Full Text] [Related]
14. Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders. Stahl SM. J Clin Psychiatry; 1999 Jun 02; 60(6):356-7. PubMed ID: 10401911 [No Abstract] [Full Text] [Related]